Skip to content

CONVERT PHARMACEUTICALS

Active Public limited companyfounded 2017active for 9 yearsEsplanade Simone VEIL 1, 4000 LiègeKBO/BCE: BE 0671.828.631

Timeline

28 events since 2017

The 2026 accounts are due by 31-07-2027.

2026
2 directors reappointed (director) and (director) · acts as permanent representative · General meeting of 17-09-20268 points ▸
  • General meeting of 17-09-2026
  • reappointed as director
  • reappointed as director
  • is in office as director
  • is in office as director
  • is in office as director
  • is in office as director
  • acts as permanent representative
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

acts as permanent representative reappointed as director · General meeting of 31-07-202610 points ▸
  • General meeting of 31-07-2026
  • Power of attorney granted to
  • Power of attorney granted to
  • Power of attorney granted to
  • is in office as director
  • is in office as director
  • is in office as director
  • is in office as director
  • acts as permanent representative
  • reappointed as director
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

appointed as directorGeneral meeting of 01-06-20265 points ▸
  • General meeting of 01-06-2026
  • appointed as director
  • Power of attorney granted to
  • Power of attorney granted to
  • Power of attorney granted to

Open the deed in the Belgian Official Gazette

Annual accounts 2025 filed NBBabbreviated format · 44 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0671828631
Registered office moved within LiègeThe registered office moved from Clos Chanmurly 13, 4000 Liège to Silversquare Guillemins - Esplanade Simone Veil 1, 4000 Liège · resigns as director · appointed as director · Board meeting of 01-07-20257 points ▸
  • Board meeting of 27-11-2024
  • Board meeting of 01-07-2025
  • Board meeting of 15-05-2025
  • resigns as director
  • appointed as director
  • General meeting of 02-06-2025
  • The registered office moved to Silversquare Guillemins - Esplanade Simone Veil 1, 4000 Liège

Open the deed in the Belgian Official Gazette

Capital increase of €952,497 to €2,222,683The capital rose from €1,270,186 to €2,222,683, with 276,086 new shares · General meeting of 24-06-20254 points ▸
  • General meeting of 24-06-2025
  • The capital was increased by €952,497
  • Capital contribution, €952,497
  • Article 5 of the articles of association amended
  • The deed holds 8 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2024 filed PDFfull format · 35 days before the deadline
2024
Liquidity more than doubled current ratio 10.41 The current ratio rises from 3.64 to 10.41.
Annual accounts 2023 filed PDFfull format · 55 days before the deadline
2023
Annual accounts 2022 filed PDFfull format · 53 days before the deadline
2022
Annual accounts 2021 filed PDFfull format · 19 days before the deadline
2021
Annual accounts 2020 filed PDFfull format · 39 days before the deadline
2020
Liquidity more than doubled current ratio 3.29 The current ratio rises from 1.38 to 3.29. Short-term debt falls from €717,410 to €163,478.
Annual accounts 2019 filed PDFfull format · 32 days before the deadline
Registered office moved within LiègeThe registered office moved from Quai Banning 6 4000 Liège to Clos Chanmurly 13, 4000 Liège · , , and resign · and act as permanent representatives12 points ▸
  • The registered office moved to Clos Chanmurly 13, 4000 Liège
  • The capital is €1,270,186, divided into 1,667,626 shares
  • resigns as director
  • acts as permanent representative
  • resigns as director
  • acts as permanent representative
  • resigns as director
  • resigns as director
  • appointed as director
  • appointed as director
  • appointed as director
  • Discharge granted to )
  • The deed holds 7 more points.

Open the deed in the Belgian Official Gazette

2019
Back to profit net €421,472 The net result is €421,472, after 2 loss-making years.
Annual accounts 2018 filed PDFfull format · 29 days before the deadline
1 director appointed, 2 resignations (director) and . (managing director) resign · appointed as director · acts as permanent representative · General meeting of 11-01-20197 points ▸
  • General meeting of 11-01-2019
  • resigns as director
  • appointed as director
  • Board meeting of 11-01-2019
  • . resigns as managing director
  • appointed as managing director
  • acts as permanent representative

Open the deed in the Belgian Official Gazette

2018
Weakest financial year net -€1.0m The net result drops to -€1.0m, the lowest from 2017 to 2025. It recovers the following year.
Annual accounts 2017 filed PDFfull format · 9 days late
2017
2 directors appointed, 1 resignation resigns as director · (director) and . (managing director) appointed · acts as permanent representative · General meeting of 02-10-20177 points ▸
  • General meeting of 02-10-2017
  • resigns as director
  • appointed as director
  • Board meeting of 02-10-2017
  • resigns as managing director
  • . appointed as managing director
  • acts as permanent representative

Open the deed in the Belgian Official Gazette

Registered office moved from Saint-Gilles to LiègeThe registered office moved from Rue d'Ecosse 28, 1060 Saint-Gilles to Quai Banning 6 4000 Liège · General meeting of 10-08-20172 points ▸
  • General meeting of 10-08-2017
  • The registered office moved to Quai Banning 6 4000 Liège

Open the deed in the Belgian Official Gazette

Capital increase of €265,626 to €1,270,186The capital rose from €1,004,560 to €1,270,186, with 265,626 new shares6 points ▸
  • The capital was increased by €265,626
  • Article 5 of the articles of association amended
  • Article 13 of the articles of association amended
  • Article 15 of the articles of association amended
  • Power of attorney granted to
  • Power of attorney granted to
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

Capital of €1,004,560, 1,402,000 shares3 points ▸
  • The capital is €1,004,560, divided into 1,402,000 shares
  • Power of attorney granted to
  • Power of attorney granted to

Open the deed in the Belgian Official Gazette

Publication in the Belgian Official Gazette PDF
IncorporationFounding capital of €504,560, 902,000 shares · Founded by (comparant), (comparant), (comparant) and 2 others · , , , and appointed · published on 28-02-201718 points ▸
  • The board has 5 directors
  • appointed as director
  • appointed as director
  • appointed as director
  • acts as permanent representative
  • appointed as director
  • acts as permanent representative
  • appointed as director
  • appointed as chair of the board
  • appointed as managing director
  • Founded by
  • Founded by
  • Founded by
  • Founded by
  • Founded by
  • The founding capital is €504,560, divided into 902,000 shares
  • Capital contribution, €154,320
  • The capital is €504,560, divided into 902,000 shares
  • The deed holds 6 more points.

Open the deed in the Belgian Official Gazette

First establishment At the time the registered office was still in Saint-Gilles, Rue d'Ecosse 28.

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

On 24 February 2017, CONVERT PHARMACEUTICALS was incorporated by , and three private individuals, with a starting capital of €504,560.12 In 2017 the registered office moved to Liège.3 The capital was increased 2 times between 2017 and 2025, most recently to €2.2m.45 Today the board has 4 members.6 Total assets went from €1.8m in 2018 to €941,204 in 2025 and headcount from 4.6 full-time equivalents in 2018 to 0.3 in 2023.7

  1. 1KBO register
  2. 2Belgian Official Gazette, 28-02-2017
  3. 3Belgian Official Gazette, 15-09-2017
  4. 4Belgian Official Gazette, 06-07-2017
  5. 5Belgian Official Gazette, 07-07-2025
  6. 6Belgian Official Gazette, 13-10-2026
  7. 7National Bank, annual accounts 2018, 2023 and 2025

Next steps